Enrique M. Ocio
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 146
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 34
- Oncology top 1%
- Peptidase Inhibition and Analysis 45
- Cancer Treatment and Pharmacology 20
-
- Lymphoma Diagnosis and Treatment 18
- Immunology top 5%
-
- Protein Degradation and Inhibitors 64
- Cancer therapeutics and mechanisms 15
- Ubiquitin and proteasome pathways 15
- Co-authors
- Jesús F. San MiguelMaría‐Victoria MateosAtanasio PandiellaRamón García‐SánzMercedes GarayoaPatricia MaisoNorma C. GutiérrezFermín Sánchez‐Guijo
- Cited by
- HematologyGeneticsOncology
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Enrique M. Ocio
200 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 123
- Hematology 2.6k
- Genetics 1.4k
- Oncology 1.9k
- Pathology and Forensic Medicine 1.1k
- Immunology 834
Countries citing papers authored by Enrique M. Ocio
This map shows the geographic impact of Enrique M. Ocio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique M. Ocio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique M. Ocio more than expected).
Fields of papers citing papers by Enrique M. Ocio
This network shows the impact of papers produced by Enrique M. Ocio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique M. Ocio. The network helps show where Enrique M. Ocio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Enrique M. Ocio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2020 | 7 | |
| 5 | 2020 | 14 | |
| 6 | 2017 | 28 | |
| 7 | 2017 | 8 | |
| 8 | 2017 | 1 | |
| 9 | 2016 | 43 | |
| 10 | OUTCOMES FOR OLDER PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN THE STRATUS (MM-010) TRIAL, A SINGLE-ARM, PHASE 3B STUDY | 2015 | 1 |
| 11 | THE STRATUS (MM-010) TRIAL: A SINGLE-ARM, PHASE 3B STUDY EVALUATING SAFETY AND EFFICACY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA | 2015 | 1 |
| 12 | 2014 | 8 | |
| 13 | 2014 | 9 | |
| 14 | 2013 | 43 | |
| 15 | 2013 | 115 | |
| 16 | 2011 | 46 | |
| 17 | 2009 | 228 | |
| 18 | Biological value of housefly larvae estimated in chickens by the crude protein method. | 1980 | 1 |
| 19 | Utilization of seeds of Vicia ervilla in the feeding of chickens. 2. Effects of the inclusion of high levels of seed for finishing chickens. | 1980 | 1 |
| 20 | Utilization of seeds of Vicia ervilla in the feeding of chickens. 1. Effects of including high levels of seed in starter diets. | 1980 | 1 |
About Enrique M. Ocio
Enrique M. Ocio is a scholar working on Hematology, Genetics and Oncology, having authored 206 papers that have together received 5.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (146 papers), Protein Degradation and Inhibitors (64 papers), Peptidase Inhibition and Analysis (45 papers), Chronic Lymphocytic Leukemia Research (34 papers), Cancer Treatment and Pharmacology (20 papers), Lymphoma Diagnosis and Treatment (18 papers), Cancer therapeutics and mechanisms (15 papers) and Ubiquitin and proteasome pathways (15 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (1.4k citations) and Oncology (1.9k citations). Enrique M. Ocio has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Jesús F. San Miguel, María‐Victoria Mateos, Atanasio Pandiella, Ramón García‐Sánz, Mercedes Garayoa, Patricia Maiso, Norma C. Gutiérrez, Fermín Sánchez‐Guijo, María‐Belén Vídriales and Laura San‐Segundo. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.